Organ-on-Chip Market (Updated Version Available)

An organ-on-a-chip (OOC) is a multi-channel 3-D microfluidic cell culture chip that simulates the activities, mechanics and physiological response of entire organs and organ systems, a type of artificial organ. It constitutes the subject matter of significant biomedical engineering research, more precisely in bio-MEMS. The convergence of labs-on-chips (LOCs) and cell biology has permitted the study of human physiology in an organ-specific context, introducing a novel model of in vitro multicellular human organisms. One day, they will perhaps abolish the need for animals in drug development and toxin testing. Organ-on-a-chip technology not only incorporates multiple cell types but also involves engineering aspects, such as the guided spatial confinement of cells or the incorporation of sensors and microfluidic channels.
Organ-on-Chip is a fledgling industry. Most companies come from university laboratories and are in the stage of financing. Very few companies are commercialized and sold on a large scale. Although most of the companies trying to enter the industry are start-ups, many large companies (such as Johnson & Johnson) are eager to try because of their wide range of applications, including pharmaceuticals, cosmetics, agriculture, food and so on. The United States, UK, the Netherlands and France have given priority to occupying most of the markets. Relatively speaking, the overall market in Asia is relatively blank. It is expected that South Korea, Japan and Taiwan will accelerate the pace of research. Product types are still mainly concentrated in the liver, kidney, heart, blood vessels and so on. The company will continue to expand the scope of research, such as bone, muscle, nerve, skin and other organs.

The report offers detailed coverage of Organ-on-Chip industry and main market trends. The market research includes historical and forecast market data, demand, application details, price trends, and company shares of the leading Organ-on-Chip by geography. The report splits the market size, by volume and value, on the basis of application type and geography.

The report forecast global Organ-on-Chip market to grow to reach xxx Million USD in 2020 with a CAGR of xx% during the period 2021-2025.

First, this report covers the present status and the future prospects of the global Organ-on-Chip market for 2015-2025.
And in this report, we analyze global market from 5 geographies: Asia-Pacific[China, Southeast Asia, India, Japan, Korea, Western Asia], Europe[Germany, UK, France, Italy, Russia, Spain, Netherlands, Turkey, Switzerland], North America[United States, Canada, Mexico], Middle East & Africa[GCC, North Africa, South Africa], South America[Brazil, Argentina, Columbia, Chile, Peru].

Key Companies
Emulate
TissUse
Hesperos
CN Bio Innovations
Tara Biosystems
Draper Laboratory
Mimetas
Nortis
Micronit Microtechnologies B.V.
Kirkstall
Cherry Biotech SAS
Else Kooi Laboratory

At the same time, we classify Organ-on-Chip according to the type, application by geography. More importantly, the report includes major countries market based on the type and application.

Market Segment as follows:
Market by Order Type
Liver-on-a-chip
Kidney-on-a-chip
Intestine-on-a-chip
Lung-on-a-chip
Heart-on-a-chip
Other Organs
Market by Application
Pharmaceutical & Biotechnology Companies
Academic & Research Institutes
Cosmetics Industry
Other End Users

By Region
Asia-Pacific[China, Southeast Asia, India, Japan, Korea, Western Asia]
Europe[Germany, UK, France, Italy, Russia, Spain, Netherlands, Turkey, Switzerland]
North America[United States, Canada, Mexico]
Middle East & Africa[GCC, North Africa, South Africa]
South America[Brazil, Argentina, Columbia, Chile, Peru]

The research provides answers to the following key questions:
• What is the estimated growth rate and market share and size of the Organ-on-Chip market for the forecast period 2021 - 2025?
• What are the driving forces in the Organ-on-Chip market for the forecast period 2021 - 2025?
• Who are the prominent market players and how have they gained a competitive edge over other competitors?
• What are the market trends influencing the progress of the Organ-on-Chip industry worldwide?
• What are the major challenges and threats restricting the progress of the industry?
• What opportunities does the market hold for the prominent market players?